Quick Answer
Prime Medicine, Inc. reported Shares Outstanding of 180.51 million shares for fiscal year 2025.
Prime Medicine, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 180.51M | +37.6% |
| 2024 | 131.16M | +34.7% |
| 2023 | 97.38M | +0.2% |
| 2022 | 97.21M | +199.9% |
| 2021 | 32.41M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 180.31M | +37.5% | +34.1% |
| June 30, 2025 | 134.49M | +12.0% | +2.5% |
| March 31, 2025 | 131.16M | +9.3% | +0.0% |
| December 31, 2024 | 131.16M | +34.7% | +0.0% |
| September 30, 2024 | 131.16M | +34.8% | +9.3% |
| June 30, 2024 | 120.03M | +23.4% | +0.0% |
| March 31, 2024 | 120.02M | +23.4% | +23.3% |
| December 31, 2023 | 97.38M | +0.2% | +0.1% |
- Prime Medicine, Inc. showed an increase of +37.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, Prime Medicine, Inc.’s shares outstanding has grown by 456.9% (from 32.41 million shares to 180.51 million shares).
- The most recent figure is from Prime Medicine, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: